These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 31570424)
1. Inhibition of PAR-1 Receptor Signaling by Enoxaparin Reduces Cell Proliferation and Migration in A549 Cells. Alturkistani A; Ghonem N; Power-Charnitsky VA; Pino-Figueroa A; Migliore MM Anticancer Res; 2019 Oct; 39(10):5297-5310. PubMed ID: 31570424 [TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. Jiang M; Zhou LY; Xu N; An Q Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884 [TBL] [Abstract][Full Text] [Related]
3. A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer. Wang J; Wang HY; Shen Y; Liang D; Wang HY; Zhang SQ; Cao YX; Cao L Anticancer Drugs; 2019 Oct; 30(9):900-908. PubMed ID: 30913062 [TBL] [Abstract][Full Text] [Related]
4. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Zhao L; Zhang J; Fan Y; Li Y Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173 [TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of α-Bisabolol in human non-small cell lung carcinoma cells are mediated via apoptosis induction, cell cycle arrest, inhibition of cell migration and invasion and upregulation of P13K/AKT signalling pathway. Wu S; Peng L; Sang H; Ping Li Q; Cheng S J BUON; 2018; 23(5):1407-1412. PubMed ID: 30570866 [TBL] [Abstract][Full Text] [Related]
6. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells. Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719 [TBL] [Abstract][Full Text] [Related]
7. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression. Xia A; Li H; Li R; Lu L; Wu X Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma. Song YH; Zhang CQ; Chen FF; Lin XY Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375 [TBL] [Abstract][Full Text] [Related]
9. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
10. Curcumol Inhibits Lung Adenocarcinoma Growth and Metastasis via Inactivation of PI3K/AKT and Wnt/-Catenin Pathway. Li S; Zhou G; Liu W; Ye J; Yuan F; Zhang Z Oncol Res; 2021 Sep; 28(7):685-700. PubMed ID: 32886059 [TBL] [Abstract][Full Text] [Related]
11. Anthricin‑induced caspase‑dependent apoptosis through IGF1R/PI3K/AKT pathway inhibition in A549 human non‑small lung cancer cells. Park BR; Lee SA; Moon SM; Kim CS Oncol Rep; 2018 Jun; 39(6):2769-2776. PubMed ID: 29620219 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway. Lee YC; Lin HH; Hsu CH; Wang CJ; Chiang TA; Chen JH Eur J Pharmacol; 2010 Apr; 632(1-3):23-32. PubMed ID: 20097193 [TBL] [Abstract][Full Text] [Related]
13. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway. You J; Cheng J; Yu B; Duan C; Peng J Med Sci Monit; 2018 Apr; 24():2126-2133. PubMed ID: 29632297 [TBL] [Abstract][Full Text] [Related]
14. Enoxaparin sensitizes human non-small-cell lung carcinomas to gefitinib by inhibiting DOCK1 expression, vimentin phosphorylation, and Akt activation. Pan Y; Li X; Duan J; Yuan L; Fan S; Fan J; Xiaokaiti Y; Yang H; Wang Y; Li X Mol Pharmacol; 2015; 87(3):378-90. PubMed ID: 25488183 [TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway. Jin H; Qiao F; Wang Y; Xu Y; Shang Y Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877 [TBL] [Abstract][Full Text] [Related]
16. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line. Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432 [TBL] [Abstract][Full Text] [Related]
17. Concentration- and time-dependent effects of enoxaparin on human adenocarcinomic epithelial cell line A549 proliferation in vitro. Abu Arab W; Kotb R; Sirois M; Rousseau E Can J Physiol Pharmacol; 2011 Oct; 89(10):705-11. PubMed ID: 21905823 [TBL] [Abstract][Full Text] [Related]
18. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70. Zhou Y; Ma J; Zhang J; He L; Gong J; Long C Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121 [TBL] [Abstract][Full Text] [Related]
19. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling. Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094 [TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way. Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]